ข่าวประชาสัมพันธ์ Bayer HealthCare

International Federation on Ageing and Bayer HealthCare Release Report Raising Awareness of How Pets Contribute to Healthy Ageing

The first-of-its-kind report investigates how pets may contribute to physical, mental and societal well-being, in an ageing global demographic With advances in global public health, people around the world are living longer than ever before[i]. In response to the ageing population, healthcare systems and governments are actively working to manage the expected healthcare costs associated with the ageing process and chronic conditions of older people. The health impact of pets on older people is

TREATMENT OF PRIMARY LIVER CANCER: SARAH STUDY NOW AVAILABLE FOR ALL ELIGIBLE PATIENTS THROUGHOUT FRANCE

Launched by the Assistance Publique Hopitaux de Paris (AP-HP) in December 2011, SARAH, a French national collaborative randomized controlled trial of radioembolization with yttrium-90 resin...

Landmark Phase III Study of Bayer's Xarelto(R) (Rivaroxaban) Initiated for the Secondary Prevention of Myocardial Infarction and Death in Patients with Coronary or Peripheral Artery Disease

Not intended for U.S. and UK Media - 20,000-patient study will be conducted in collaboration with Population...

วันคุมกำเนิดโลก ปี 55 ผลสำรวจชี้ หญิงเอเชียคุมกำเนิดน้อย แม้อยากจะชะลอการมีบุตร

วันคุมกําเนิดโลก ปี 55 ผลสำรวจชี้ หญิงเอเชียคุมกําเนิดน้อย แม้อยากจะชะลอการมีบุตรชาย-หญิงไทย คุมกำเนิดไม่ถูกวิธี เลือกหลั่งข้างนอก และกินยาคุมฉุกเฉิน ให้ผลไม่ 100% ผลงานวิจัย โดยไบเออร์ เฮลธ์แคร์ (Bayer HealthCare) พบ ชาย...

“Young And Sexy” free magazine launched to create the right attitude toward birth control pills

Bayer Thai Co., Ltd., one of the world's leading, innovative companies in the healthcare and medical products industry, launched “Young And Sexy” magazine to educate women on proper use of birth control...

Sirtex Medical Limited: New Study of Primary Liver Cancer Seeks to Enroll 400 French Patients

'SARAH' a French national collaborative randomized controlled trial of radioembolization with yttrium-90 resin microspheres versus sorafenib in advanced hepatocellular carcinoma is now open for recruitment...

Medtronic and Bayer Diabetes Care Announce Alliance To Provide Blood Glucose Meter to Medtronic Patients Outside the United States

New Blood Glucose Meter to Provide Advanced Therapy Options for People with Diabetes Beginning in Canada and Europe Medtronic, Inc. (NYSE: MDT) and Bayer Diabetes Care, a...